Patents Assigned to The Board of Trustee of the Leland Stanford Junior
University
-
Patent number: 11975123Abstract: A method of preventing tissue adhesion includes forming an incision in tissue, applying a hydrogel to tissue through the incision, and closing the incision with the hydrogel therein. The hydrogel includes a polymer non-covalently cross-linked with a plurality of nanoparticles and prevents a formation of adhesions between tissues and/or organs.Type: GrantFiled: October 1, 2019Date of Patent: May 7, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Eric Andrew Appel, Y. Joseph Woo, Lyndsay Stapleton
-
Patent number: 11977312Abstract: Provided is an optical modulator including a substrate, and a plurality of meta units provided on the substrate and spaced apart from each other, wherein at least one of the plurality of meta units includes a metal layer provided on the substrate, a dielectric layer provided an upper surface and side surfaces of the metal layer, and an antenna provided on an upper surface of the dielectric layer, the antenna including phase change material, wherein a refractive index of the phase change material changes based on a voltage applied to the metal layer to modulate incident light.Type: GrantFiled: August 4, 2021Date of Patent: May 7, 2024Assignees: SAMSUNG ELECTRONICS CO., LTD., The Board of Trustees of the Leland Stanford Junior UniversityInventors: Junghyun Park, Mark L. Brongersma, Yifei Wang
-
Patent number: 11979028Abstract: Described is a locomotive implant for usage within a predetermined magnetic field. In one embodiment magnetohydrodynamics is used to generate thrust with a plurality of electrodes. In another embodiment, asymmetric drag forces are used to generate thrust.Type: GrantFiled: September 27, 2021Date of Patent: May 7, 2024Assignee: The Board of Trustees of The Leland Stanford Junior UniversityInventors: Daniel M. Pivonka, Anatoly Anatolievich Yakovlev, Ada Shuk Yan Poon, Teresa H. Meng
-
Patent number: 11974981Abstract: Methods and compositions are provided for treating endometriosis in an individual, and the pain associated with endometriosis. Aspects of the methods include administering to the individual an agent that promotes ALDH activity.Type: GrantFiled: February 25, 2022Date of Patent: May 7, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Eric Gross, Daria Mochly-Rosen, Stacy Lynn McAllister
-
Publication number: 20240144584Abstract: A method of training a neural network model to generate a three-dimensional (3D) model of a scene includes: generating the 3D model based on a latent code; based on the 3D model, sampling a camera view including a camera position and a camera angle corresponding to the 3D model of the scene; generating a two-dimensional (2D) image based on the 3D model and the sampled camera view; and training the neural network model to, using the 3D model, generate a scene corresponding to the sampled camera view based on the generated 2D image and a real 2D image.Type: ApplicationFiled: July 24, 2023Publication date: May 2, 2024Applicants: Samsung Electronics Co., Ltd., The Board of Trustees of the Leland Stanford Junior UniversityInventors: Minjung SON, Jeong Joon PARK, Gordon WETZSTEIN
-
Publication number: 20240144663Abstract: A system is disclosed that includes a computer that includes a processor and a memory, the memory including instructions executable by the processor to input an image acquired by a sensor to a neural network to output a prediction regarding an object included in the image. The neural network can be trained, based on (a) a distributed robust optimization that minimizes an expectation applied to probability distributions of loss functions to select training images that yield a solution with a selected uncertainty level and (b) generating additional input images based on adversarial images.Type: ApplicationFiled: November 1, 2022Publication date: May 2, 2024Applicants: Ford Global Technologies, LLC, The Board of Trustees of the Leland Stanford Junior UniversityInventors: Xinru Hua, Huanzhong Xu, Jose Blanchet, Viet Anh Nguyen, Marcos Paul Gerardo Castro
-
Patent number: 11969526Abstract: A tissue adhesion prevention hydrogel is provided and engineered with essential features for maintaining separation between tissues and organs in any part of the body, thus preventing adhesion formation, are their shear-thinning, viscoelasticity, and rapid self-healing. A method of using the tissue adhesion prevention hydrogel for tissue adhesion prevention is also provided. A method of interposing the tissue adhesion prevention in between tissue layers for tissue adhesion prevention is further provided.Type: GrantFiled: April 2, 2018Date of Patent: April 30, 2024Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYInventors: Eric Andrew Appel, Y. Joseph Woo, Lyndsay Stapleton
-
Patent number: 11973233Abstract: A catalyst structure includes: (1) a substrate; (2) a catalyst layer on the substrate; and (3) an adhesion layer disposed between the substrate and the catalyst layer. In some implementations, an average thickness of the adhesion layer is about 1 nm or less. In some implementations, a material of the catalyst layer at least partially extends into a region of the adhesion layer. In some implementations, the catalyst layer is characterized by a lattice strain imparted by the adhesion layer.Type: GrantFiled: December 11, 2020Date of Patent: April 30, 2024Assignees: The Board of Trustees of the Leland Stanford Junior University, Volkswagen AktiengesellschaftInventors: Friedrich B. Prinz, Shicheng Xu, Yongmin Kim, Thomas Jaramillo, Drew C. Higgins, Maha Yusuf, Zhaoxuan Wang, Kyung Min Lee, Marat Orazov, Dong Un Lee, Tanja Graf, Thomas Schladt, Gerold Huebner, Hanna-Lena Wittern, Jonathan Edward Mueller
-
Patent number: 11969433Abstract: Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.Type: GrantFiled: August 22, 2019Date of Patent: April 30, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Helen M. Blau, Andrew Tri Van Ho, Adelaida R. Palla
-
Publication number: 20240131196Abstract: Embodiments herein describe systems and methods to enhance RNA stability and uses thereof. Many embodiments alter the sequence of an RNA therapeutic molecule (e.g., vaccines) to encode for a variant peptide while maintaining and/or increasing stability of the RNA therapeutic.Type: ApplicationFiled: June 30, 2021Publication date: April 25, 2024Applicant: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Rhiju Das, Hannah K. Wayment-Steele
-
Patent number: 11963998Abstract: Compositions and methods are provided for the generation or treatment of chronic tympanic membrane perforation by modulation of HB-EGF activity.Type: GrantFiled: December 20, 2021Date of Patent: April 23, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Peter Luke Santa Maria, Yunzhi Yang, Sungwoo Kim, Chloe Domville-Lewis
-
Patent number: 11965215Abstract: Processes and materials to detect cancer from a biopsy are described. In some cases, cell-free nucleic acids can be sequenced, and the sequencing result can be utilized to detect sequences derived from a neoplasm. Detection of somatic variants occurring in phase can indicate the presence of cancer in a diagnostic scan and a clinical intervention can be performed.Type: GrantFiled: February 10, 2023Date of Patent: April 23, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: David M. Kurtz, Maximilian Diehn, Arash Ash Alizadeh
-
Patent number: 11965034Abstract: Compositions and methods are provided for treating fibrosis in a mammal by administering a therapeutic dose of a pharmaceutical composition.Type: GrantFiled: February 9, 2022Date of Patent: April 23, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Gerlinde Wernig, Irving L. Weissman
-
Patent number: 11965780Abstract: Improved resolution of a time-varying optical measurement is provided with optical intensity modulator(s) having a bandwidth greater than that of the detector array(s). The modulator configuration can have high photon collection efficiency, e.g. by using polarization modulation to split the incident light into several time-gated channels.Type: GrantFiled: August 29, 2022Date of Patent: April 23, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Adam Bowman, Mark A. Kasevich, Brannon Klopfer
-
Patent number: 11968263Abstract: A method and a system for managing power resources. One or more measurements received from one or more sensors communicatively coupled to at least one processor are processed. The sensors monitor and measure at least one of: one or more operational parameters associated with operation of at least one equipment, one or more external parameters associated with an environment of the equipment, and one or more power parameters associated with a power consumption by the equipment. Based on the processed one or more measurements, one or more future operational parameters associated with an operation of the are determined. The operation of the equipment is controlled using the determined future operational parameters.Type: GrantFiled: March 24, 2022Date of Patent: April 23, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Ram Rajagopal, Gustavo Vianna Cezar, Thomas Navidi, Elizabeth Buechler, Abbas El Gamal
-
Publication number: 20240124895Abstract: In certain aspects, the present invention provides methods for inducing a stable gene modification of a target nucleic acid via homologous recombination in a primary cell, such as a primary blood cell and/or a primary mesenchymal cell. In certain other aspects, the present invention provides methods for enriching a population of genetically modified primary cells having targeted integration at a target nucleic acid. The methods of the present invention rely on the introduction of a DNA nuclease such as a Cas polypeptide and a homologous donor adeno-associated viral (AAV) vector into the primary cell to mediate targeted integration of the target nucleic acid. Also provided herein are methods for preventing or treating a disease in a subject in need thereof by administering to the subject any of the genetically modified primary cells or pharmaceutical compositions described herein to prevent the disease or ameliorate one or more symptoms of the disease.Type: ApplicationFiled: December 5, 2022Publication date: April 18, 2024Applicant: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Daniel P. Dever, Rasmus O. Bak, Ayal Hendel, Waracharee Srifa, Matthew H. Porteus
-
Publication number: 20240124520Abstract: N-Acylated histidine dipeptides of formula are disclosed. The compounds are useful for treating breast cancer.Type: ApplicationFiled: October 10, 2020Publication date: April 18, 2024Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYInventors: Michael BRUNO, Jijuan GU URBAN, Jennifer LI-POOK-THAN, Teri SLIFER, Michael SNYDER
-
Patent number: 11961837Abstract: In certain examples, methods and semiconductor structures are directed to an integrated circuit (IC) having a diamond layer section and a GaN-based substrate being monolithically integrated or bonded as part of the same IC. In a specific example, the GaN-based substrate includes GaN, AlxGayN (0<x<1; x+y=1) and a dielectric layer, and a diamond layer section which may include polycrystalline diamond. The IC includes: a GaN-based field effect transistor (FET) integrated with a portion of the GaN-based substrate, and a diamond-based FET integrated with a portion of the diamond layer section, the diamond FET being electrically coupled to the GaN-based FET and situated over or against a surface region of the GaN-based substrate.Type: GrantFiled: January 7, 2022Date of Patent: April 16, 2024Assignees: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of CaliforniaInventors: Srabanti Chowdhury, Mohamadali Malakoutian, Matthew A. Laurent, Chenhao Ren, Siwei Li
-
Patent number: 11957787Abstract: Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.Type: GrantFiled: September 22, 2020Date of Patent: April 16, 2024Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Jill Helms, Girija Dhamdhere
-
Publication number: 20240120023Abstract: Methods for identifying biosynthetic gene clusters that include genes for producing compounds that interact with specific target proteins are disclosed. Some methods relate to bioinformatics methods for identifying and/or prioritizing biosynthetic gene clusters. Related systems, components, and tools for the identification and expression of such gene clusters are also disclosed.Type: ApplicationFiled: July 7, 2023Publication date: April 11, 2024Applicant: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Brian Thomas Naughton, Colin Harvey, Ulrich Schlecht, Maureen Elizabeth Hillenmeyer, Joe Horecka